Analyst consensus rating
Zymeworks Analyst Rating: Strong Buy
ZYME is rated Strong Buy by 12 analysts with a $40.33 target. As of 2026-08-19.
Direct answer
Zymeworks's consensus rating is Strong Buy.
12 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $40.33.
Forecast evidence checked August 19, 2026.
Get free Zymeworks email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $27.51
- Average price target
- $40.33
- High price target
- $58.00
- Low price target
- $31.00
- Low target gap
- +12.7%
- Target upside
- +46.6%
- High target gap
- +110.8%
- Target range width
- 98.1%
- Consensus rating
- Strong Buy
- Analysts
- 12
- Evidence date
- August 19, 2026
- Valid through
- August 26, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Zymeworks?
Zymeworks has a verified Strong Buy consensus. The same dataset has an average price target of $40.33.
How far are Zymeworks's low and high targets from the recorded price?
The low target implies +12.7%, while the high target implies +110.8%.
How many analysts are included in Zymeworks's consensus?
The verified consensus includes 12 analysts.
How is Zymeworks's target upside or downside calculated?
The average target of $40.33 is divided by the recorded price of $27.51, then one is subtracted to produce +46.6%. This does not guarantee a future return.
When was Zymeworks's analyst forecast verified?
The data was verified on 2026-08-19. The dataset is valid through 2026-08-26.